Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching

Purpose Penetrating keratoplasty can restore vision in corneal blindness. However, immunologic rejection threatens graft survival. Matching donors at swine leukocyte antigen (SLA)-class II convey allo-specific tolerance in a large animal kidney-transplantation model despite mismatches at SLA-class I. The same matching pattern seems to account for the blood transfusion effect in kidney transplantation. Relying on the molecular basis of HLAMatchmaker eplets, we assessed whether this finding would also apply to keratoplasty, and if it would enhance the benefit from matching human leukocyte antigen (HLA)-class I alone. Methods We retrospectively selected two independent cohorts comprising 586 and 975 penetrating keratoplasties. Our computations revealed a quantitative tolerogenicity factor analogous to the animal model. The number of mismatched HLA-class I eplets functioned as a factor for conventional histocompatibility. In the first cohort, we empirically determined the thresholds with the highest predictive power on graft rejection for both factors, and confirmed those thresholds in the second cohort. We applied Cox proportional hazards regression for these analyses. Results The thresholds with highest predictive power revealed 220 eplets2 for the tolerance factor and 10 eplets for HLA-class I histocompatibility. The respective hazards ratios were 2.22 (p=0.04) versus 3.63 (p<0.01) in the first cohort and 2.09 (p<0.01) versus 1.51 (p=0.02) in the second, confirmatory cohort. The threshold factors proved to be additive in predicting immune reactions in both cohorts, (hazard ratios 2.66 in cohort 1 versus 1.70; p<0.01 in cohort 2). Conclusions Operational tolerance may be inducible by balanced matching of HLA-class I and II HLAMatchmaker eplets. Furthermore, such tolerance is additive to histocompatibliity at HLA-class I.

[1]  D. Böhringer,et al.  Distinct cytokine pattern in aqueous humor during immune reactions following penetrating keratoplasty , 2010, Molecular vision.

[2]  R. Duquesnoy,et al.  HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies , 2009, Current opinion in organ transplantation.

[3]  W. Burlingham,et al.  Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts. , 2009, Transplant immunology.

[4]  B. Seitz,et al.  Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study , 2009, Eye.

[5]  D. Coster,et al.  The Immunobiology of Corneal Transplantation , 2007, Transplantation.

[6]  Medhat Askar,et al.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. , 2007, Human immunology.

[7]  D. Coster,et al.  The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. , 2005, American journal of ophthalmology.

[8]  D. Roelen,et al.  The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. , 2005, Transfusion medicine reviews.

[9]  D. Böhringer,et al.  Immunosuppression with Cyclosporine A and Mycophenolate Mofetil After Penetrating High-Risk Keratoplasty: A Retrospective Study , 2005, Transplantation.

[10]  S. Kim-Schulze,et al.  Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. , 2005, International immunopharmacology.

[11]  P. Wernet,et al.  Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. , 2004, Ophthalmology.

[12]  D. Heisey,et al.  Immune Regulation and Graft Survival in Kidney Transplant Recipients Are Both Enhanced by Human Leukocyte Antigen Matching , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  F. Claas,et al.  Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty1 , 2004, Transplantation.

[14]  I. Doxiadis,et al.  Long-Term Outcome in High-Risk Corneal Transplantation and the Influence of HLA-A and HLA-B Matching , 2003, Cornea.

[15]  I. Doxiadis,et al.  HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1 , 2003, Transplantation.

[16]  T. Ichim,et al.  Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance 1 , 2003, The Journal of Immunology.

[17]  S. Böhringer,et al.  Predicting time on the waiting list for HLA matched corneal grafts. , 2002, Tissue antigens.

[18]  H. Völker‐Dieben,et al.  BENEFICIAL EFFECT OF HLA-DR MATCHING ON THE SURVIVAL OF CORNEAL ALLOGRAFTS1 , 2000, Transplantation.

[19]  P. Wernet,et al.  Rapid method for successful HLA class I and II typing from cadaveric blood for direct matching in cornea transplantation , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[21]  D. Sachs,et al.  Effect of major histocompatibility complex matching on the development of tolerance to primarily vascularized renal allografts: a study in miniature swine. , 1996, Human immunology.

[22]  S. Gore,et al.  Negative effect of HLA-DR matching on corneal transplant rejection. , 1995, Transplantation proceedings.

[23]  T. Sundt,et al.  INDUCTION OF SPECIFIC TOLERANCE TO CLASS I‐DISPARATE RENAL ALLOGRAFTS IN MINIATURE SWINE WITH CYCLOSPORINE , 1992, Transplantation.

[24]  M. Maguire,et al.  Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Group (corrected) , 1992, Human Immunology.